**Specifications Table**TableSubject areaBiologyMore specific subject areaBreast cancerType of dataTable, FigureHow data was acquiredMicroarray analysis: microarray was processed using Affymetrix GeneChip Whole Transcript (WT) Sense Target Labeling Assay and quantified Affymetrix image files were analyzed using the *Bioconductor* package OneChannelGUI into the statistical software environment R.Bioinformatics analysis: functional enrichment analysis was done using the gene list from the microarray analysis and Ingenuity pathway core analysis (IPA^®^, QIAGEN Redwood City).Data formatAnalyzed and filtered dataExperimental factorsT47D cells were transfected with 17β-HSD1 siRNAs followed by estradiol treatment two days later for an additional two days, and total RNA was extracted for analysis.Experimental features3×10^5^ T47D cells were transfected in 6-well plates in charcoal-treated medium with 200 nM mixed 17β-HSD1 specific siRNAs or with negative control siRNA. Two days later, transfected cells were treated with 1 nM estradiol or *ethanol* as a *vehicle control* in fresh charcoal-treated medium and cells were incubated for two additional days before RNA extraction and analysis.Data source locationN/AData accessibilityData is available within this article and available at the NCBI database via Gene Expression Omnibus (GEO accession number [GSE77345](ncbi-geo:GSE77345){#ir0005}).

**Value of the data**•Provide information on genes regulated by 17β-HSD1 and its product estradiol, useful for further studies on breast cancer cell mechanisms.•Can contribute to elucidate hormone-independent cell growth pathways in hormone-dependent breast cancer cells.•May stimulate further research on understanding 17β-HSD1 roles in breast cancer development.

1. Data {#s0005}
=======

[Table 1](#t0005){ref-type="table"} showed data on gene expression profile in T47D cells (genes regulated 1.5 time or higher) transfected with 17β-HSD1 siRNAs (si17B1) or negative control siRNA (NC), and treated with 1 nM estradiol (E2), revealed by microarray analysis with contrast NC+E2 *vs.* si17B1+E2 (see [Table 5](#t0025){ref-type="table"} for additional information). [Table 2](#t0010){ref-type="table"} showed the 14 functional terms found in the cancer category of the IPA biological function analysis of 208 genes from three fold change lists (genes which fold change equal or higher than 1.5 in at least one contrast), generated by the three contrasts (NC *vs.* si17B1; NC *vs.* NC+E2; and NC+E2 *vs.* si17B1+E2) of microarray analyses (see [Table 5](#t0025){ref-type="table"} for contrast description). [Table 3](#t0015){ref-type="table"} showed the 14 functional terms found in the cell death and survival category of the IPA biological function analysis of 208 genes generated by the three contrasts of microarray analyses. [Table 4](#t0020){ref-type="table"} showed data on the IPA network analysis of 208 genes from the three contrasts (NC *vs.* si17B1; NC *vs.* NC+E2; and NC+E2 *vs.* si17B1+E2) of the microarray analysis. [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"} showed IPA Canonical pathway analyses for interferon signaling pathway in the NC *vs.* NC+E2 contrast ([Fig. 1](#f0005){ref-type="fig"}), antigen presentation pathway in the NC *vs.* si17B1 contrast ([Fig. 2](#f0010){ref-type="fig"}), antigen presentation pathway in the NC *vs.* NC+E2 contrast ([Fig. 3](#f0015){ref-type="fig"}), and role of BRCA1 in DNA damage response in the NC *vs.* NC+E2 contrast ([Fig. 4](#f0020){ref-type="fig"}).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cell culture, siRNA transfections, steroid treatment and RNA preparation {#s0015}
-----------------------------------------------------------------------------

T47D cells were obtained from the American Type Culture Collection (ATCC) and were cultured as described in ref [@bib1]. The detailed procedure of siRNA transfections, steroid treatment and RNA preparation have been described in ref [@bib1]. Briefly, two days before transfection, T47D cells were cultured in dextran-coated charcoal-treated medium; on the transfection day, 3×10^5^ cells were reverse-transfected in 6-well plates with 200 nM mixed 17β-HSD1 specific siRNAs [@bib2], [@bib3] (si17B1) or with Scramble siRNA used as negative control siRNA (NC) using Lipofectamine siRNAMax (Invitrogen), and cells were incubated in steroid deprived medium. Two days after transfection, cell culture media were replaced by fresh charcoal-treated medium containing either the steroid estradiol (1 nM) or *ethanol* as a *vehicle control* (*see* [Table 5](#t0025){ref-type="table"}), and cells were incubated for two more days before RNA extraction using Trizol Reagent (Invitogen). The RNA samples included two independent biological replicates, coming from two independent cell culture experiments, for a total of eight RNA samples.

2.2. Microarray processing {#s0020}
--------------------------

RNA samples were processed according to the manufacturer׳s recommended procedures on GeneChip Whole Transcript (WT) Sense Target Labeling Assay from Affymetrix (<http://www.affymetrix.com/support/downloads/manuals/wt_sensetarget_label_manual.pdf>). The assay was started with 0.2 µg of each T47D cells RNA samples and the protocol is based on the principle of performing one cycle of cDNA synthesis and in vitro transcription (IVT) for target amplification to generate cRNA following by reverse transcription reactions to synthesis the WT cDNA. About 2.7 µg sample of fragmented cDNAs was used to hybridize human oligonucleotide array Gene 1.0 ST (Genechip; Affymetrix). The array comprised more than 750,000 unique 25-mer oligonucleotides constituting over 28,000 gene-level probe sets of the human genome. The cDNA probe corresponding to each biological repetition for each condition was hybridized on separate arrays. After hybridization, chips were processed using the Affymetrix GeneChip Fluidic Station 450 (protocol F450_0007). Chips were scanned with a GeneChip scanner 3000 7G (Affymetrix) and images were extracted with the GeneChip operating software (Affymetrix GCOS v1.4). The microarray processing was performed at the DNA Biochip Platform service at CHU de Québec - CHUL Research Centre (Québec, Canada).

2.3. Microarray analysis {#s0025}
------------------------

The microarray analysis has been described in the accompanying paper [@bib1]. *Quantified Affymetrix image* files (\".CEL\" files) for each of the treatment conditions (including two independent replicates per treatment condition) were used to perform the microarray analyses using the *Bioconductor* package OneChannelGUI [@bib4], [@bib5] in the statistical software environment R. Three contrasts (see [Table 5](#t0025){ref-type="table"}) were using the RMA method [@bib6]. Data filtering was performed at signal feature level by interquantile range (IQR) then by intensity. To identify differentially expressed genes, gene expression intensity was compared using a moderated *t*-test and a Bayes smoothing approach developed for a low number of replicates [@bib7], and the false discovery rate was estimated from *P-values* derived from the moderated *t*-test statistics for correction for the effect of multiple testing [@bib8]. Genes were considered to be significantly differentially expressed if *p-values* were \<0.05. The log~2~ transformed signal intensities were averaged, and the mean value was used to compute the fold changes. Genes that were differentially expressed 1.5-fold or higher were considered for subsequent analyses. Our microarray data is available in the Gene Expression Omnibus (GEO) repository, accession number [GSE77345](ncbi-geo:GSE77345){#ir0015}.

2.4. Functional enrichment analysis {#s0030}
-----------------------------------

Ingenuity pathway analysis (IPA^®^, QIAGEN Redwood City, [www.qiagen.com/ingenuity](http://www.qiagen.com/ingenuity){#ir0020}) was used to assess the functional enrichment of the 208 modulated genes revealed by the three-contrast microarray analysis (genes which fold change equal or higher than 1.5 in at least one contrast). Three analyses made by IPA were presented here: identification of biological functions, gene networks and canonical pathways (see ref for additional information). Criteria used for the IPA analyses have been described in the accompanying research article [@bib1].

This work was supported by Canadian Institutes of Health Research, Canada, with grant to S.-X. Lin (Principal Investigator for FRN57892).

![IPA Canonical Pathway analysis showing the interferon signaling pathway across the NC *vs.* NC+E2 contrast data.](gr1){#f0005}

![Canonical pathways by IPA: antigen presentation pathway in the NC *vs.* si17B1 contrast.](gr2){#f0010}

![Canonical pathways by IPA: antigen presentation pathway in the NC *vs.* NC+E2 contrast.](gr3){#f0015}

![Canonical pathways by IPA: role of BRCA1 in DNA damage response in the NC *vs.* NC+E2 contrast.](gr4){#f0020}

###### 

List of the 140 genes induced or repressed 1.5 time or higher (*p*\<0.05) in T47D cells after transfection with 17β-HSD1 siRNAs (si17B1) or negative control siRNA (NC) for two days and cell treatment with 1 nM estradiol (E2). Data was obtained from microarray analysis using contrast NC+E2 *vs.* si17B1+E2 (see [Table 5](#t0025){ref-type="table"}).

  Symbol          Description                                                                       Fold change
  --------------- --------------------------------------------------------------------------------- -------------
  CDH10           Cadherin 10, type 2 (T2-cadherin)                                                 5,2
  IFI44           Interferon-induced protein 44                                                     4,7
  IFIT2           Interferon-induced protein with tetratricopeptide repeats 2                       4,6
  IFIT3           Interferon-induced protein with tetratricopeptide repeats 3                       4,4
  RSAD2           Radical S-adenosyl methionine domain containing 2                                 4,3
  DDX60L          DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like                                    4,0
  CCL5            Chemokine (C-C motif) ligand 5                                                    3,4
  IFIT1           Interferon-induced protein with tetratricopeptide repeats 1                       3,4
  ARL4D           ADP-ribosylation factor-like 4D                                                   3,3
  NAALADL2        N-acetylated alpha-linked acidic dipeptidase-like 2                               3,2
  BTN3A2          Butyrophilin, subfamily 3, member A2                                              3,1
  LBA1            Lupus brain antigen 1                                                             3,1
  DDX60           DEAD (Asp-Glu-Ala-Asp) box polypeptide 60                                         3,0
  XAF1            XIAP associated factor 1                                                          2,9
  MDGA2           MAM domain containing glycosylphosphatidylinositol anchor 2                       2,9
  OAS2            2׳-5׳-oligoadenylate synthetase 2, 69/71 kDa                                      2,9
  RARRES3         Retinoic acid receptor responder (tazarotene induced)                             2,9
  HCP5            HLA complex P5                                                                    2,9
  OASL            2׳-5׳-oligoadenylate synthetase-like                                              2,9
  PARP14          Poly (ADP-ribose) polymerase family, member 14                                    2,8
  IFITM3          Interferon induced transmembrane protein 3 (1-8U)                                 2,8
  LAMP3           Lysosomal-associated membrane protein 3                                           2,7
  AKAP6           A kinase (PRKA) anchor protein 6                                                  2,7
  PSMB9           Proteasome subunit beta type-9                                                    2,7
  BTN3A1          Butyrophilin, subfamily 3, member A1                                              2,7
  RANBP3L         RAN binding protein 3-like                                                        2,6
  HLA-F           Major histocompatibility complex, class I, F                                      2,5
  IFITM1          Interferon induced transmembrane protein 1 (9--27)                                2,5
  DDX58           DEAD (Asp--Glu--Ala--Asp) box polypeptide 58                                      2,5
  BTN3A3          Butyrophilin, subfamily 3, member A3                                              2,5
  ERBB4           V-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)                  2,5
  HLA-H           Major histocompatibility complex, class I, H (pseudogene)                         2,4
  HLA-A           Major histocompatibility complex, class I, A                                      2,4
  PARP9           Poly (ADP-ribose) polymerase family, member 9                                     2,4
  HLA-C           Major histocompatibility complex, class I, C                                      2,3
  CTSO            Cathepsin O                                                                       2,3
  L3MBTL3         L(3)mbt-like 3 (Drosophila)                                                       2,3
  HLA-E           Major histocompatibility complex, class I, E                                      2,3
  IFI35           Interferon-induced protein 35                                                     2,3
  HLA-B           Major histocompatibility complex, class I, B                                      2,3
  APOL1           Apolipoprotein L, 1                                                               2,3
  HLA-G           Major histocompatibility complex, class I, G                                      2,3
  HERC6           Hect domain and RLD 6                                                             2,2
  HERC5           Hect domain and RLD 5                                                             2,2
  IFIH1           Interferon induced with helicase C domain 1                                       2,2
  SLC46A3         Solute carrier family 46, member 3                                                2,2
  VGLL1           Vestigial like 1 (Drosophila)                                                     2,2
  TAP1            Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)                       2,2
  FGF12           Fibroblast growth factor 12                                                       2,2
  PLSCR1          Phospholipid scramblase 1                                                         2,2
  HLA-A29,1       Major histocompatibility complex class I HLA-A29,1                                2,2
  LGALS3BP        Lectin, galactoside-binding, soluble, 3 binding protein                           2,2
  SAMD9           Sterile alpha motif domain containing 9                                           2,2
  ATP1B1          Atpase, Na+/K+ transporting, beta 1 polypeptide                                   2,1
  OAS1            2׳,5׳-oligoadenylate synthetase 1, 40/46kda                                       2,1
  PSMB8           Proteasome subunit beta type-9                                                    2,1
  OAS3            2׳-5׳-oligoadenylate synthetase 3, 100kda                                         2,1
  CENTD1          Centaurin, delta 1                                                                2,1
  IFI27           Interferon, alpha-inducible protein 27                                            2,1
  DHX58           DEXH (Asp--Glu--X-His) box polypeptide 58                                         2,1
  STAT2           Signal transducer and activator of transcription 2, 113kda                        2,0
  LAMC1           Laminin, gamma 1 (formerly LAMB2)                                                 2,0
  THSD7A          Thrombospondin, type I, domain containing 7A                                      2,0
  TGFB2           Transforming growth factor, beta 2                                                2,0
  USP18           Ubiquitin specific peptidase 18                                                   2,0
  MX1             Interferon-induced GTP-binding protein Mx1                                        2,0
  B2M             Beta-2-microglobulin                                                              2,0
  DTX3L           Deltex 3-like (Drosophila)                                                        2,0
  ERAP1           Endoplasmic reticulum aminopeptidase 1                                            2,0
  SLC15A3         Solute carrier family 15, member 3                                                1,9
  CFB /// C2      Complement factor B /// complement component 2                                    1,9
  TNFSF10         Tumor necrosis factor (ligand) superfamily, member 10                             1,9
  ROBO2           Roundabout homolog 2                                                              1,9
  IL1R1           Interleukin 1 receptor, type I                                                    1,9
  RAB27B          RAB27B, member RAS oncogene family                                                1,9
  RTP4            Receptor (chemosensory) transporter protein 4                                     1,9
  STAT1           Signal transducer and activator of transcription 1, 91kda                         1,9
  CASP4           Caspase 4, apoptosis-related cysteine peptidase                                   1,9
  INSIG2          Insulin induced gene 2                                                            1,9
  DKFZP434B2016   Similar to hypothetical protein LOC284701                                         1,9
  SMARCA1         Nucleosome-remodeling factor subunit SNF2L                                        1,8
  LIPH            Lipase, member H                                                                  1,8
  ZNFX1           Zinc finger, NFX1-type containing 1                                               1,8
  UBP1            Upstream binding protein 1 (LBP-1a)                                               1,8
  KLF8            Kruppel-like factor 8                                                             1,8
  LRRK2           Leucine-rich repeat kinase 2                                                      1,8
  LTBP1           Latent transforming growth factor beta binding protein 1                          1,8
  EVI1            Ecotropic viral integration site 1                                                1,8
  FBXO32          F-box protein 32                                                                  1,7
  BCAS1           Breast carcinoma amplified sequence 1                                             1,7
  ALCAM           Activated leukocyte cell adhesion molecule                                        1,7
  MTERFD3         MTERF domain containing 3                                                         1,6
  MMP16           Matrix metallopeptidase 16                                                        1,6
  LOC390345       Similar to ribosomal protein L10                                                  1,6
  CITED2          Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2   1,6
  CYP4Z2P         Cytochrome P450, family 4, subfamily Z, polypeptide 2 pseudogene                  1,6
  RNF43           Ring finger protein 43                                                            1,6
  ZNF175          Zinc finger protein 175                                                           1,5
  SEPP1           Selenoprotein P, plasma, 1                                                        1,5
  EPAS1           Endothelial PAS domain protein 1                                                  1,5
  FAM115A         Family with sequence similarity 115, member A                                     1,5
  SEMA6A          Semaphorin 6A                                                                     1,5
  NBEA            Neurobeachin                                                                      1,5
  CSAD            Cysteine sulfinic acid decarboxylase                                              1,5
  SNX24           Sorting nexin 24                                                                  −1,5
  RBBP8           Retinoblastoma binding protein 8                                                  −1,5
  PTTG1           Pituitary tumor-transforming 1                                                    −1,5
  ELOVL2          Elongation of very long chain fatty acids protein 2                               −1,5
  KCTD6           Potassium channel tetramerisation domain containing 6                             −1,5
  AURKA           Aurora kinase A                                                                   −1,5
  KIF18A          Kinesin family member 18A                                                         −1,5
  ARHGAP11A       Rho GTPase activating protein 11A                                                 −1,5
  CDKN3           Cyclin-dependent kinase inhibitor 3                                               −1,5
  PRR11           Proline rich 11                                                                   −1,5
  C13orf3         Chromosome 13 open reading frame 3                                                −1,5
  SPAG5           Sperm associated antigen 5                                                        −1,6
  CA8             Carbonic anhydrase VIII                                                           −1,6
  PLK1            Polo-like kinase 1 (Drosophila)                                                   −1,6
  SGOL1           Shugoshin-like 1 (S, pombe)                                                       −1,6
  CCNA2           Cyclin A2                                                                         −1,6
  CDC20           Cell division cycle 20                                                            −1,6
  NUF2            NUF2, NDC80 kinetochore complex component                                         −1,6
  KIF20A          Kinesin family member 20A                                                         −1,6
  ANP32E          Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E                  −1,7
  RPL22           Ribosomal protein L22                                                             −1,7
  PBK             PDZ binding kinase                                                                −1,7
  PTGES           Prostaglandin E synthase                                                          −1,7
  HEY2            Hairy/enhancer-of-split related with YRPW motif 2                                 −1,8
  SNORD27         Small nucleolar RNA, C/D box 27                                                   −1,8
  SLC47A1         Solute carrier family 47, member 1                                                −1,8
  ESCO2           Establishment of sister chromatid cohesion N-acetyltransferase 2                  −1,9
  C14orf129       Chromosome 14 open reading frame 129                                              −1,9
  FLNA            Filamin A, alpha (actin binding protein 280)                                      −1,9
  CTSD            Cathepsin D                                                                       −2,0
  RBM24           RNA binding motif protein 24                                                      −2,0
  POLE3           Polymerase (DNA directed), epsilon 3 (p17 subunit)                                −2,1
  LOC440093       Histone H3-like                                                                   −2,2
  AHNAK2          AHNAK nucleoprotein 2                                                             −2,2
  AREG            Amphiregulin                                                                      −2,3
  RCN2            Reticulocalbin 2, EF-hand calcium binding domain                                  −2,3

###### 

The 14 functional terms found in the cancer category of the IPA biological function analysis of 208 genes regulated by 17β-HSD1 and/or estradiol in T47D cells.

Table 2

  Number   Functional term
  -------- -------------------------------------------
  1        Cancer
  2        Breast cancer
  3        Delay in tumorigenesis
  4        Growth of tumor
  5        Incidence of tumor
  6        Mammary tumor
  7        Neoplasia of tumor cell lines
  8        Triple-negative breast cancer
  9        Tumorigenesis of breast cancer cell lines
  10       Tumorigenesis of cells
  11       Tumorigenesis of mammary adenocarcinoma
  12       Tumorigenesis of mammary gland
  13       Tumorigenesis of mammary tumor
  14       Tumorigenesis of tumor cell lines

###### 

The 14 functional terms found in the cell death and survival category of the IPA Biological function analysis of 208 genes regulated by 17β-HSD1 and/or estradiol in T47D cells.

Table 3

  Number   Functional term
  -------- ---------------------------------------
  1        Apoptosis
  2        Apoptosis of breast cancer cell lines
  3        Apoptosis of breast cell lines
  4        Apoptosis of mammary epithelial cells
  5        Apoptosis of mammary tumor cells
  6        Apoptosis of tumor cell lines
  7        Cell death
  8        Cell death of tumor cell lines
  9        Cell survival
  10       Cell viability
  11       Cytotoxicity of cells
  12       Cytotoxicity of cytotoxic T cells
  13       Cytotoxicity of T lymphocytes
  14       Necrosis

###### 

IPA network analysis of 208 genes regulated by 17β-HSD1 and/or estradiol in T47D cells from the three contrasts listed in [Table 5](#t0025){ref-type="table"}.

***Molecules in Network***: All of the molecules that compose each network are listed.

***Score***: The score is based on a *p*-value calculation, which calculates the likelihood that the Network Eligible Molecules that are part of a network are found therein by random chance alone. Mathematically, the score is simply the negative exponent of the right-tailed Fisher׳s exact test result. For example, if the score is 3, then the there is a 1 in 1000 chance that the Network Eligible Molecules found in that network appeared there just by chance. In other words, the score is simply a measure of the number of Network Eligible Molecules in a network, and the greater the number of Network Eligible Molecules in a network, the higher the score (lower the p-value) will be.

***Focus Molecules***: This column simply indicates the number of Network Eligible Molecules per network. Since the maximum number of molecules per network is currently limited to 35, the number of Network Eligible Molecules per network cannot exceed 35.

***Top Functions***: Only the three most significant functions for each network are listed.

  ID   Molecules in network                                                                                                                                                                                                                                                                                                                                                                    Score   Focus molecules   Top functions
  ---- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ----------------- ----------------------------------------------------------------------------------------------------------------
  1    2׳ 5׳ oas, Akt, DDX58, DDX60, DHX58, FBXO32, Fcer1, HERC5, IFIT1, IFIT3, IFITM1, IFITM3, Ifn, IFN Beta, Interferon alpha, IRF, MX1, N-cor, OAS1, OAS2, OAS3, Oas, PARP9, PBK, PI3K (family), RARRES3, RCN2, RSAD2, SEMA6A, STAT2, STAT-1/2, Thioredoxin reductase, TXNRD1, USP18, VTCN1                                                                                                 42      23                Antimicrobial response, inflammatory response, inflammatory disease
  2    Alpha catenin, Alpha tubulin, AREG/AREGB, Cadherin, CDH10, Cg, CITED2, EPAS1, ERBB2, ERBB4, estrogen receptor, FKBP4, GNMT, GREB1, Hdac, Histone h3, Hsp70, Hsp90, ID1, MCM10, PFKFB3, PGR, Pkc(s), POLE3, PTGES, RBBP8, RNA polymerase II, RPL22, SMARCA1, SPINK4, STC2, STEAP2, TCF, TM4SF1, Ubiquitin                                                                                38      22                Connective tissue development and function, embryonic development, organ development
  3    androstenediol, ARL4D, C5AR2, CD97, CSAD, CYP1A1, EID3, ESR1, FLRT3, HLA-C, ICAM3, IL6, KCNF1, KCNH1, KCTD6, L3MBTL3, LRRK2, mir-19, miR-149-3p (and other miRNAs w/seed GGGAGGG), miR-183-5p (miRNAs w/seed AUGGCAC), miR-19b-3p (and other miRNAs w/seed GUGCAAA), MTERFD3, NAALADL2, NMU, RAB27B, RAPGEFL1, RCN2, RNF135, SLC46A3, SLC47A1, Slco1a1, SOX13, SPC25, THSD7A, TMEM116   38      21                Organismal injury and abnormalities, reproductive system development and function, reproductive system disease
  4    ADRB, APC (complex), AURKA, BRCA2, BUB1, calpain, CASP4, caspase, CCNA2, CCNB2, Cdc2, CDC20, Cdk, CKS2, Cyclin A, Cyclin B, Cyclin D, Cyclin E, E2f, FLNA, Ifn gamma, MAP2K1/2, NDC80, NFkB (complex), NFYB, NUF2, PLK1, PP2A, PTTG1, RAD51, Rb, RWDD2A, SGOL1, SPAG5, XAF1                                                                                                             33      19                Cell cycle, cellular assembly and organization, dna replication, recombination, and repair
  5    AKAP8L, ANP32E, APEH, ARHGAP11A, BTN3A1, CEP152, DTX3L, FAM115A, FBXO38, FDPS, FTSJ3, HMG CoA synthase, IFRD2, INSIG2, KLF8, LGALS7/LGALS7B, LRRC41, MDGA2, NBEA, OAS3, PABPC4, PARP9, PHF7, PPM1G, PRR11, PXMP4, RBM24, RHOBTB1, RNASEH2B, RNF43, SKA3, SNRPA, SPC24, UBC, ZNF622                                                                                                      30      18                Hereditary disorder, neurological disease, psychological disorders
  6    20s proteasome, B2M, CD8, ERAP1, ERK1/2, H-2db, HLA Class I, HLA-A, Hla-abc, HLA-B27, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, IFI27, IFI35, IFI44, IFIH1, IFIT2, IFN alpha/beta, IFN type 1, Interferon-Î± Induced, ISGF3, KIR, LGALS3BP, MHC, MHC Class I (complex), MHC CLASS I (family), MHC I-Î±, PSMB8, PSMB9, Stat1-Stat2, TAP1, Tap                                                   28      17                Endocrine system disorders, gastrointestinal disease, immunological disease
  7    AHNAK2, ANKRD27, ARL8B, BRCA2, BTN3A3, CA8, CBX8, CEP170, CKAP2L, CPAMD8, CTSL1, DDX6L, DLG5, DNPEP, ESCO2, EXOC1, FAM72A, GOLGA4, HCST, HIC1, KIF18A, KIF20A, KIF4A, LIPH, LPXN, MICB, PSMD14, RAB6A, RAB6B, SNX24, TAZ, TUBGCP2, UBC, ZNF175, ZRANB2                                                                                                                                  28      17                Connective tissue disorders, dermatological diseases and conditions, developmental disorder
  8    26s Proteasome, Actin, ARAP2, BTN3A2, C8orf44-SGK3/SGK3, FGF12, GNB1, GNG11, GSK3B, GSKIP, HCP5, IFI35, IFNG, IFNL3, IL19, IRF, IRGM, LAMP3, miR-21-5p (and other miRNAs w/seed AGCUUAU), MOV10, MTORC2, Oas, PLA2, PSMB9, PSME2, RANBP3L, RSAD2, RTP4, SAMD9, SLC15A3, SLC9A3, SOCS, STAT, uric acid, USP18                                                                            26      16                Dermatological diseases and conditions, infectious disease, cell-to-cell signaling and interaction
  9    AKAP6, ALCAM, APOL1, CDKN3, CREBZF, CTSD, DDIT4, FBP1, FSH, Gsk3, hemoglobin, HISTONE, Histone h4, IKK (complex), Insulin, KCNMA1, Lh, Mapk, MYC, Notch, OASL, p85 (pik3r), Pka, PRKAC, Rac, Ras, Ras homolog, ROBO2, SELENBP1, Shc, SOX2, TCR, TRIP13, Vegf, ZNFX1                                                                                                                     25      16                Cellular growth and proliferation, tissue development, cell morphology
  10   Alp, Ap1, Cbp/p300, CCL5, CDCA5, Collagen type I, Collagen type IV, Collagen(s), ELOVL2, ERK, Focal adhesion kinase, HEY2, IL1R1, Integrin, JAK, KYNU, LAMC1, Laminin1, Laminin, LDL, LTBP1, Mek, MYB, p70 S6k, Pdgf (complex), PDGF BB, Pias, PXK, Smad, Smad2/3, Sos, STAT5a/b, Tgf beta, TGFB2, THBS1                                                                                18      12                Cardiovascular disease, embryonic development, organ development
  11   alpha-estradiol, androstenediol, ATP12A, ATP1B1, BCAS1, beta-estradiol, CD40, Ck2, CTSO, EGFR, EGFR ligand, Egfr-Erbb2, ERBB, ganglioside GD1a, GRM4, IER2, IFI30, IFNE, Igf, LTB, mir-146, miR-29b-3p (and other miRNAs w/seed AGCACCA), Mmp, OLFM1, PTGDS, PVRL4, RAC1, RERG, SEPP1, SERPINA6, TAP1, TP53INP1, UBP1, VGLL1, Wap                                                       18      12                Cell morphology, cellular assembly and organization, cellular development
  12   AMPK, BCR (complex), CD3, cytochrome C, F Actin, HERC6, Hsp27, Ige, IgG1, IgG, Igm, Ikk (family), IL1, IL12 (complex), IL12 (family), Immunoglobulin, Jnk, MECOM, MHC Class II (complex), MYBL1, P38 MAPK, PARP14, PARP, PI3K (complex), PLC gamma, PLSCR1, Pro-inflammatory Cytokine, Rsk, Rxr, S100A8, SRC (family), STAT1, Tlr, Tnf (family), TNFSF10                                10      8                 Cellular development, hematological system development and function, hematopoiesis

###### 

Summary of the cell experiments and microarray analyses.

Table 5

  **T47D cell transfections and treatment**                                                                                                                                                                                                                                                                 
  ------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------------- ------------------------------------------- --------------------------------------------------------------- -----------
  Day 1                                       Transfection with negative control (NC) or 17β-HSD1 (si17B1) siRNAs   NC                                                                          si17B1                                      NC                                                              si17B1
  Day 3                                       Addition of estradiol (+E2) or the *vehicle control (−)*              --                                                                          --                                          +E2                                                             +E2
  Day 5                                       Cell wash and total RNA extraction                                    NC                                                                          si17B1                                      NC+E2                                                           si17B1+E2
                                                                                                                                                                                                                                                                                                            
  **Microarray analyses**                                                                                                                                                                                                                                                                                   
  Three contrasts                             Contrast 1: NC *vs.* si17B1                                           Contrast 2: NC *vs.* NC+E2                                                  Contrast 3: NC+E2 *vs.* si17B1+E2                                                                           
  Aim                                                                                                               List T47D genes impacted by 17β-HSD1 knockdown in steroid-deprived medium   List genes responsive to estrogen in T47D   To detect if E2 impacts gene regulation by 17β-HSD1 knockdown   
